Effect of the Dialysis Fluid Buffer on Peritoneal Membrane Function in Children

被引:20
作者
Schmitt, Claus Peter [1 ]
Nau, Barbara [1 ]
Gemulla, Gita [1 ]
Bonzel, Klaus E. [2 ]
Holtta, Tuula [3 ]
Testa, Sara [4 ]
Fischbach, Michel [5 ]
John, Ulrike [6 ]
Kemper, Markus J. [7 ]
Sander, Anja [8 ]
Arbeiter, Klaus [9 ]
Schaefer, Franz [1 ]
机构
[1] Univ Childrens Hosp, Heidelberg, Germany
[2] Univ Childrens Hosp, Essen, Germany
[3] Univ Childrens Hosp, Helsinki, Finland
[4] Univ Childrens Hosp, Milan, Italy
[5] Univ Childrens Hosp, Strasbourg, France
[6] Univ Childrens Hosp, Jena, Germany
[7] Univ Childrens Hosp, Hamburg, Germany
[8] Heidelberg Univ, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany
[9] Univ Childrens Hosp, Vienna, Austria
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2013年 / 8卷 / 01期
关键词
GLUCOSE DEGRADATION-PRODUCTS; RESIDUAL RENAL-FUNCTION; MESOTHELIAL CELLS; LONG-TERM; NEUTRAL-PH; RAT MODEL; BICARBONATE; LACTATE; TRIAL; BIOCOMPATIBILITY;
D O I
10.2215/CJN.00690112
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Double-chamber peritoneal dialysis fluids exert less toxicity by their neutral pH and reduced glucose degradation product content. The role of the buffer compound (lactate and bicarbonate) has not been defined in humans. Design, setting, participants, & measurements A multicenter randomized controlled trial in 37 children on automated peritoneal dialysis was performed. After a 2-month run-in period with conventional peritoneal dialysis fluids, patients were randomized to neutral-pH, low-glucose degradation product peritoneal dialysis fluids with 35 mM lactate or 34 mM bicarbonate content. Clinical and biochemical monitoring was performed monthly, and peritoneal equilibration tests and 24-hour clearance studies were performed at 0, 3, 6, and 10 months. Results No statistically significant difference in capillary blood pH, serum bicarbonate, or oral buffer supplementation emerged during the study. At baseline, peritoneal solute equilibration and clearance rates were similar. During the study, 4-hour dialysis to plasma ratio of creatinine tended to increase, and 24-hour dialytic creatinine and phosphate clearance increased with lactate peritoneal dialysis fluid but not with bicarbonate peritoneal dialysis fluid. Daily net ultrafiltration, which was similar at baseline (lactate fluid=5.4 +/- 2.6 ml/g glucose exposure, bicarbonate fluid=4.9 +/- 1.9 ml/g glucose exposure), decreased to 4.6 +/- 1.0 ml/g glucose exposure in the lactate peritoneal dialysis fluid group, whereas it increased to 5.1 +/- 1.7 m/g glucose exposure in the bicarbonate content peritoneal dialysis fluid group (P=0.006 for interaction). Conclusions When using biocompatible peritoneal dialysis fluids, equally good acidosis control is achieved with lactate and bicarbonate buffers. Improved long-term preservation of peritoneal membrane function may, however, be achieved with bicarbonate-based peritoneal dialysis fluids. Clin J Am Soc Nephrol 8: 108-115, 2013. doi: 10.2215/CJN.00690112
引用
收藏
页码:108 / 115
页数:8
相关论文
共 42 条
[1]   Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose [J].
Albrektsson, Ann ;
Bazargani, Farhan ;
Wieslander, Anders ;
Braide, Magnus .
ASAIO JOURNAL, 2006, 52 (03) :276-281
[2]   Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer [J].
Brizel, DM ;
Schroeder, T ;
Scher, RL ;
Walenta, S ;
Clough, RW ;
Dewhirst, MW ;
Mueller-Klieser, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (02) :349-353
[3]  
Choi HY, 2008, PERITON DIALYSIS INT, V28, P174
[4]  
Erixon M, 2006, PERITON DIALYSIS INT, V26, P490
[5]   Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription [J].
Fischbach, M ;
Stefanidis, CJ ;
Watson, AR .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (03) :380-385
[6]   Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids [J].
Frischmann, Matthias ;
Spitzer, Johanna ;
Fuenfrocken, Michael ;
Mittelmaier, Stefan ;
Deckert, Melanie ;
Fichert, Thomas ;
Pischetsrieder, Monika .
BIOMEDICAL CHROMATOGRAPHY, 2009, 23 (08) :843-851
[7]  
Furkert J, 2008, PERITON DIALYSIS INT, V28, P637
[8]   Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study [J].
Haag-Weber, Marianne ;
Kraemer, Rosemarie ;
Haake, Ruediger ;
Islam, Mohamed Shariful ;
Prischl, Friedrich ;
Haug, Ulrike ;
Nabut, Jose L. ;
Deppisch, Reinhold .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (07) :2288-2296
[9]   Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis [J].
Haas, S ;
Schmitt, CP ;
Arbeiter, K ;
Bonzel, KE ;
Fischbach, M ;
John, U ;
Pieper, AK ;
Schaub, TP ;
Passlick-Deetjen, J ;
Mehls, O ;
Schaefer, F .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (10) :2632-2638
[10]   Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions [J].
Han, Seung Hyeok ;
Ahn, Song Vogue ;
Yun, Jee Young ;
Tranaeus, Anders ;
Han, Dae-Suk .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (04) :711-720